4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001613377-16-000009
Options or other derivatives
- Chief Science/Medical Officer acquired 19,016 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
STRAYER DAVID R · Chief Science/Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-15 | Grant or award : show line 1 in the form Incentive Rights | +19,016 | $0.14 | $2,662 | 19,016 | D |
Loading xslF345X03/primary_doc.xml…